BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21136916)

  • 1. Sample handling for mass spectrometric proteomic investigations of human urine.
    Petri AL; Høgdall C; Christensen IJ; Simonsen AH; T'jampens D; Hellmann ML; Kjaer SK; Fung ET; Høgdall E
    Proteomics Clin Appl; 2008 Sep; 2(9):1184-93. PubMed ID: 21136916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
    Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
    Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
    Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
    Simonsen AH; Bahl JM; Danborg PB; Lindstrom V; Larsen SO; Grubb A; Heegaard NH; Waldemar G
    J Neurosci Methods; 2013 May; 215(2):234-40. PubMed ID: 23537933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies.
    Gika HG; Theodoridis GA; Wilson ID
    J Chromatogr A; 2008 May; 1189(1-2):314-22. PubMed ID: 18096175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis.
    Papale M; Pedicillo MC; Di Paolo S; Thatcher BJ; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    Clin Chem Lab Med; 2008; 46(1):89-99. PubMed ID: 18020972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample handling for mass spectrometric proteomic investigations of human sera.
    West-Nielsen M; Høgdall EV; Marchiori E; Høgdall CK; Schou C; Heegaard NH
    Anal Chem; 2005 Aug; 77(16):5114-23. PubMed ID: 16097747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
    Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
    J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
    Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
    Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry.
    Roelofsen H; Alvarez-Llamas G; Schepers M; Landman K; Vonk RJ
    Proteome Sci; 2007 Jan; 5():2. PubMed ID: 17224053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of freeze/thaw cycles on several biomarkers in urine from patients with kidney disease.
    Zhang Y; Luo Y; Lu H; Wang N; Shen Y; Chen R; Fang P; Yu H; Wang C; Jia W
    Biopreserv Biobank; 2015 Apr; 13(2):144-6. PubMed ID: 25880475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary protein/peptide profiling with SELDI-TOF-MS.
    Schipper R; Loof A; de Groot J; Harthoorn L; van Heerde W; Dransfield E
    Ann N Y Acad Sci; 2007 Mar; 1098():498-503. PubMed ID: 17435159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.
    Timms JF; Arslan-Low E; Gentry-Maharaj A; Luo Z; T'Jampens D; Podust VN; Ford J; Fung ET; Gammerman A; Jacobs I; Menon U
    Clin Chem; 2007 Apr; 53(4):645-56. PubMed ID: 17303688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.